908 Devices (MASS) FCF Margin Growth (3y) (2023 - 2026)
908 Devices (MASS) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 60.00 |
| 10 | 908 Devices | 385.95 Mn | 284.42 Mn | 8.34 Mn | 8,675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,675.00 |
| Mar 31, 2026 | 12,086.00 |
| Dec 31, 2025 | 5,020.00 |
| Sep 30, 2025 | 601.00 |
| Jun 30, 2025 | 7,676.00 |
| Mar 31, 2025 | -14,256.00 |
| Dec 31, 2024 | 3,875.00 |
| Sep 30, 2024 | -1,753.00 |
| Jun 30, 2024 | -575.00 |
| Mar 31, 2024 | 3,571.00 |
| Dec 31, 2023 | -4,673.00 |
| Sep 30, 2023 | -16,773.00 |
| Jun 30, 2023 | -4,837.00 |
| Mar 31, 2023 | -3,070.00 |